Results
1
1 companies
argenx
Market Cap: €41.5b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€668.00
7D
0.3%
1Y
16.1%
